Musi Gennaro, Luzzago Stefano, Mauri Giovanni, Mistretta Francesco Alessandro, Varano Gianluca Maria, Vaccaro Chiara, Guzzo Sonia, Maiettini Daniele, Di Trapani Ettore, Della Vigna Paolo, Bianchi Roberto, Bonomo Guido, Ferro Matteo, Tian Zhe, Karakiewicz Pierre I, de Cobelli Ottavio, Orsi Franco, Piccinelli Mattia Luca
Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Oncology and Haemato-Oncology, Università degli Studi di Milano, 20122 Milan, Italy.
Diagnostics (Basel). 2023 Sep 15;13(18):2955. doi: 10.3390/diagnostics13182955.
Our objective was to develop a new, simple, and ablation-specific nephrometry score to predict peri-operative outcomes and to compare its predictive accuracy to PADUA and RENAL scores. Overall, 418 patients were treated with percutaneous thermal ablation (microwave and radiofrequency) between 2008 and 2021. The outcome of interest was trifecta status (achieved vs. not achieved): incomplete ablation or Clavien-Dindo ≥ 3 complications or postoperative estimated glomerular filtration rate decrease ≥ 30%. First, we validated the discrimination ability of the PADUA and RENAL scoring systems. Second, we created and internally validated a novel scoring (SuNS) system, according to multivariable logistic regression models. The predictive accuracy of the model was tested in terms of discrimination and calibration. Overall, 89 (21%) patients did not achieve trifecta. PADUA and RENAL scores showed poor ability to predict trifecta status (c-indexes 0.60 [0.53-0.67] and 0.62 [0.55-0.69], respectively). We, therefore, developed the SuNS model (c-index: 0.74 [0.67-0.79]) based on: (1) contact surface area; (2) nearness to renal sinus or urinary collecting system; (3) tumour diameter. Three complexity classes were created: low (3-4 points; 11% of no trifecta) vs. moderate (5-6 points; 30% of no trifecta) vs. high (7-8 points; 65% of no trifecta) complexity. Limitations include the retrospective and single-institution nature of the study. In conclusion, we developed an immediate, simple, and reproducible ablation-specific nephrometry score (SuNS) that outperformed PADUA and RENAL nephrometry scores in predicting peri-operative outcomes. External validation is required before daily practice implementation.
我们的目标是开发一种新的、简单的、针对消融术的肾计量评分系统,以预测围手术期结果,并将其预测准确性与PADUA和RENAL评分进行比较。2008年至2021年期间,共有418例患者接受了经皮热消融术(微波和射频)治疗。感兴趣的结果是三联成功状态(实现与否):消融不完全或Clavien-Dindo≥3级并发症或术后估计肾小球滤过率下降≥30%。首先,我们验证了PADUA和RENAL评分系统的鉴别能力。其次,我们根据多变量逻辑回归模型创建并内部验证了一种新的评分(SuNS)系统。从鉴别和校准方面测试了该模型的预测准确性。总体而言,89例(21%)患者未实现三联成功。PADUA和RENAL评分在预测三联成功状态方面能力较差(c指数分别为0.60[0.53-0.67]和0.62[0.55-0.69])。因此,我们基于以下因素开发了SuNS模型(c指数:0.74[0.67-0.79]):(1)接触表面积;(2)与肾窦或泌尿系统的接近程度;(3)肿瘤直径。创建了三个复杂程度类别:低(3-4分;未实现三联成功的占11%)、中(5-6分;未实现三联成功的占30%)、高(7-8分;未实现三联成功的占65%)复杂程度。局限性包括研究的回顾性和单机构性质。总之,我们开发了一种即时、简单且可重复的针对消融术的肾计量评分(SuNS),在预测围手术期结果方面优于PADUA和RENAL肾计量评分。在日常实践应用之前需要进行外部验证。